Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Bickel

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
HIV Medicine|May 30, 2024
Recently acquired HCV infection in men who have sex with men in Germany in the direct-acting antivirals era and during the COVID-19 pandemicPatrick Ingiliz, Thomas Lutz, Knud Schewe, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2023
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 yearsChristiana Graf, Lara Fuhrmann, Thomas Lutz, et al.
Cancer|September 30, 2021
Outcomes of men with HIV and germ cell cancer: Results from an international collaborative studyMarcus Ulrich Hentrich, Mark Bower, Gedske Daugaard, et al.
AIDS Research and Therapy|August 17, 2021
Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohortTrevor A Crowell, Haoyu Qian, Carsten Tiemann, et al.
Open Forum Infectious Diseases|September 23, 2020
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS StudyChristoph D Spinner, Tim Kümmerle, Jochen Schneider, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 8, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019Hendrik Streeck, Klaus Jansen, Trevor A Crowell, et al.
Infection|August 22, 2025
Practice guidelines for outpatient parenteral antimicrobial therapy (OPAT) in GermanyLukas Tometten, Ulrike Trost, Linda Jürgens, et al.
Pharmacological Research|October 18, 2025
Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trialHans-Jürgen Stellbrink, Torsten Schaller, Kerstin Sturm, et al.
The Lancet. Infectious Diseases|March 21, 2025
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort studyDavid Hillus, Ngoc Han Le, Pinkus Tober-Lau, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
HIV Medicine|May 30, 2024
Recently acquired HCV infection in men who have sex with men in Germany in the direct-acting antivirals era and during the COVID-19 pandemicPatrick Ingiliz, Thomas Lutz, Knud Schewe, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2023
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 yearsChristiana Graf, Lara Fuhrmann, Thomas Lutz, et al.
Cancer|September 30, 2021
Outcomes of men with HIV and germ cell cancer: Results from an international collaborative studyMarcus Ulrich Hentrich, Mark Bower, Gedske Daugaard, et al.
AIDS Research and Therapy|August 17, 2021
Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohortTrevor A Crowell, Haoyu Qian, Carsten Tiemann, et al.
Open Forum Infectious Diseases|September 23, 2020
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS StudyChristoph D Spinner, Tim Kümmerle, Jochen Schneider, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 8, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019Hendrik Streeck, Klaus Jansen, Trevor A Crowell, et al.
Infection|August 22, 2025
Practice guidelines for outpatient parenteral antimicrobial therapy (OPAT) in GermanyLukas Tometten, Ulrike Trost, Linda Jürgens, et al.
Pharmacological Research|October 18, 2025
Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trialHans-Jürgen Stellbrink, Torsten Schaller, Kerstin Sturm, et al.
The Lancet. Infectious Diseases|March 21, 2025
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort studyDavid Hillus, Ngoc Han Le, Pinkus Tober-Lau, et al.
Pageof 7